Abeona Therapeutics (ABEO) Non-Current Deffered Revenue (2010 - 2026)

Abeona Therapeutics (ABEO) posted quarterly Non-Current Deffered Revenue of $425000.0 for Q1 2026, down 86.12% quarter-over-quarter from $3.1 million in Q4 2017.

Abeona Therapeutics (ABEO) Non-Current Deffered Revenue (2010 - 2026) Analysis & Trends

Abeona Therapeutics' Non-Current Deffered Revenue history runs 9 years deep, the most recent figure standing at $425000.0 for Q1 2026.

  • In Q1 2026, Non-Current Deffered Revenue changed N/A year-over-year to $425000.0; the TTM figure through Mar 2026 stood at $425000.0 (changed N/A YoY), while the FY2017 annual figure was $3.1 million, down 16.46% from the prior year.
  • Non-Current Deffered Revenue for Q1 2026 stood at $425000.0, down from $3.1 million in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $425000.0 in Q1 2026, with the low at $425000.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 220.40 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Abeona Therapeutics 342.78 Mn 195.96 Mn 7.20 Mn 677,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 677,000.00
Mar 31, 2026 425,000.00
Dec 31, 2017 3.06 Mn
Sep 30, 2017 3.21 Mn
Jun 30, 2017 3.36 Mn
Mar 31, 2017 3.51 Mn
Dec 31, 2016 3.66 Mn
Sep 30, 2016 3.81 Mn
Jun 30, 2016 3.97 Mn
Mar 31, 2016 4.12 Mn
Dec 31, 2015 4.27 Mn
Sep 30, 2015 4.42 Mn
Jun 30, 2015 4.57 Mn
Mar 31, 2015 4.72 Mn
Dec 31, 2014 4.87 Mn
Sep 30, 2014 5.02 Mn
Jun 30, 2014 5.17 Mn
Mar 31, 2014 5.32 Mn
Dec 31, 2013 5.24 Mn
Sep 30, 2013 5.39 Mn